Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „when“
Suchtreffer
Begriffe & Kennungen
Besremi · 4.5 · Therefore, care should be taken when ropeginterferon alfa-2b is co- substrates notably those having a narrow t
Eintrag öffnenBetmiga · 4.5 · Other interactions No clinically relevant interactions have been observed when mirabegron was co-administered
Eintrag öffnenBetmiga · 4.5 · Other interactions No clinically relevant interactions have been observed when mirabegron was co-administered
Eintrag öffnenBexsero · 4.5 · When given concomitantly with other vaccines Bexsero must be administered at separate injection sites (see sec
Eintrag öffnenBeyfortus · 4.5 · Nirsevimab should not be mixed with any vaccine in the same syringe or vial (see section 6.2). When administer
Eintrag öffnenBeyfortus · 4.5 · There is limited experience of co-administration with vaccines. In clinical trials, when nirsevimab was given
Eintrag öffnenBlincyto · 4.8 · The duration of hepatic adverse reactions has generally been brief and with rapid resolution, often when conti
Eintrag öffnenBondronat · 4.5 · 18 Aminoglycosides Caution is advised when bisphosphonates are administered with aminoglycosides, since both s
Eintrag öffnenBondronat · 4.5 · Bioavailability was reduced by approximately 75% when Bondronat tablets were administered 2 hours after a stan
Eintrag öffnenBondronat · 4.5 · Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower
Eintrag öffnenBondronat · 4.5 · Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower
Eintrag öffnenBortezomib Accord · 4.3 · When Bortezomib Accord is given in combination with other medicinal products, refer to their Summaries of Prod
Eintrag öffnenBortezomib Accord · 4.3 · When Bortezomib Accord is given in combination with other medicinal products, refer to their Summaries of Prod
Eintrag öffnenBosulif · 4.5 · Based on the large reduction in bosutinib exposure that occurred when bosutinib was co-administered with rifam
Eintrag öffnenBosulif · 4.5 · Proton pump inhibitors (PPIs) Caution should be exercised when administering bosutinib concomitantly with PPIs
Eintrag öffnenBraftovi · 4.8 · 20 CK elevation and rhabdomyolysis CK elevation and rhabdomyolysis occurred when encorafenib is used in combin
Eintrag öffnenBraftovi · 4.8 · Dermatitis acneiform Melanoma and NSCLC Dermatitis acneiform was reported when encorafenib is used in combinat
Eintrag öffnenBraftovi · 4.8 · Hypertension Hypertension was reported when encorafenib was used in combination with binimetinib in melanoma a
Eintrag öffnenBraftovi · 4.8 · Left ventricular dysfunction LVD was reported when encorafenib is used in combination with binimetinib in mela
Eintrag öffnenBraftovi · 4.8 · Venous thromboembolism VTE was reported when encorafenib is used in combination with binimetinib in melanoma a
Eintrag öffnen